Wockhardt Ltd
₹1350.90
(2.66)%
Tue, 03 Feb 2026, 07:06 am
Health Technology
Pharmaceuticals: Major
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
21363.66
Net Profit
-57
P/B
5.30
Sector P/E
31.51
P/E
0
EV/EBITDA
54.71
Debt/Equity (Industry)
0.22
Interest Cover (Industry)
10.71
ROCE (Industry)
11.89
RONW (Industry)
11.62
ROE
-1.48
ROCE
3.87
Debt/Equity
0.57
EPS (TTM)
4.34
Dividend Yield
0
Book Value
281.07
Interest Cover
0.94
Analysis
all
- Wockhardt has been profitable on average in the past, therefore cash runway is not a concern.
- Wockhardt has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (33.1%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1x debt.
- Wockhardt's cash and other short term assets cover its long term commitments.
- Unable to calculate sustainability of dividends as Wockhardt has not reported any payouts.
- Unable to evaluate Wockhardt's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Wockhardt's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Wockhardt's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- The level of debt compared to net worth has increased over the past 5 years (30.7% vs 77.2% today).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 49.08 | 49.08 | 49.09 | 49.09 | 49.09 |
| FII | 6.99 | 7.09 | 7.28 | 6.81 | 6.54 |
| DII | 10.55 | 11.01 | 11.01 | 10.59 | 9.82 |
| Public | 33.36 | 32.80 | 32.60 | 33.50 | 34.54 |
| Government | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1803.40 | 1609.40 | 1495.80 | 1415.40 | 1301.80 | 1221.40 | 1027.40 |
| Fibonacci | 1609.40 | 1535.29 | 1489.51 | 1415.40 | 1341.29 | 1295.51 | 1221.40 |
| Camarilla | 1435.55 | 1417.77 | 1399.98 | 1415.40 | 1364.42 | 1346.63 | 1328.85 |
Pivots Level: Classic
R3
+388
1803.40
R2
+194
1609.40
R1
+80.40
1495.80
S1
-113.60
1301.80
S2
-194
1221.40
S3
-388
1027.40
Moving Average
Period
Value
10-EMA
1359.61
20-EMA
1374.21
30-EMA
1379.56
50-EMA
1384.32
100-EMA
1402.03
200-EMA
1395.16
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 03 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 16 Jul 2025 | agm | ||
| 05 Jun 2024 | agm | ||
| 21 Jul 2023 | agm | ||
| 21 Jul 2022 | agm | ||
| 03 Mar 2022 | rights | 3:10 Rights Issue of Equity Shares | 09 Mar 2022 |
| 08 Jul 2021 | agm |
Peer Comparison
Wockhardt Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Divis Laboratories Ltd
About Wockhardt Ltd
Wockhardt is a global pharmaceutical and biotech company with presence in UK, Switzerland, Ireland, Russia and many other countries. It has manufacturing and research facilities in India & UK and a manufacturing facility in Ireland and Dubai. The Group has a significant presence in Europe and India.(Source : 202503-Annual Report Page No:95)
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1999
Headquarters
CEO
H F Khorakiwala
Employees
Contact
Website
http://www.wockhardt.com
investorrelations@wockhardt.com
Phone
91-240-6694444
Location
D-4 MIDC, Chikalthana, Aurangabad., Maharashtra, 431006
wockhardt ltd History
| Year | History |
|---|---|
| 2018 |
|
| 2019 |
|
| 2020 |
|
| 2021 |
|
| 2022 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800